Histopathological response (HR) after neoadjuvant chemotherapy (ChT) for high-risk soft tissue sarcomas (STS): A planned analysis of the ISG-STS-1001 trial.
In: Journal of Clinical Oncology, Jg. 41 (2023-06-02), S. 11511-11511
Online
academicJournal
Zugriff:
Titel: |
Histopathological response (HR) after neoadjuvant chemotherapy (ChT) for high-risk soft tissue sarcomas (STS): A planned analysis of the ISG-STS-1001 trial.
|
---|---|
Autor/in / Beteiligte Person: | Pasquali, Sandro ; Collini, Paola ; Romagosa, Cleofe ; Coindre, Jean Michel ; Pizzamiglio, Sara ; Verderio, Paolo ; Barisella, Marta ; Palmerini, Emanuela ; Quagliuolo, Vittorio ; Martin Broto, Javier ; Lopez-Pousa, Antonio ; Grignani, Giovanni ; Blay, Jean-Yves ; Lugowska, Iwona A. ; Fontana, Valeria ; Sbaraglia, Marta ; Bague, Silvia ; De Tos, Paolo ; Casali, Paolo G ; Gronchi, Alessandro |
Link: | |
Zeitschrift: | Journal of Clinical Oncology, Jg. 41 (2023-06-02), S. 11511-11511 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 0732-183X (print) |
DOI: | 10.1200/JCO.2023.41.16_suppl.11511 |
Sonstiges: |
|